Sign up for free insights newsletter
DX

Diaceutics PLC

DXRXLondon Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

GBX 164.00
-0.30%
End of day
Market Cap

$139.22M

P/E Ratio

N/A

Employees

213

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-6.9139.46-0.280.232.080.334.21
Calmar-0.280.181.560.140.49
Sharpe-9.7714.07-0.180.141.220.191.27
Omega0.003.860.991.061.291.091.34
Martin-80.23-0.470.373.830.29-3.31
Ulcer0.340.9510.0312.1110.0420.2611.61

Diaceutics PLC (DXRX) Price Performance

Diaceutics PLC (DXRX) trades on London Stock Exchange in GBX. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at GBX164.00, down 0.30% from the previous close.

Over the past year, DXRX has traded between a low of GBX113.00 and a high of GBX172.00. The stock has gained 38.4% over this period. It is currently 45.1% above its 52-week low.

Diaceutics PLC has a market capitalization of $139.22M.

About Diaceutics PLC

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Compare Diaceutics PLC

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
London Stock Exchange
Currency
GBX

Financial Metrics

Revenue (TTM)
$34.40M
EBITDA
$1.33M
Profit Margin
-4.42%
EPS (TTM)
-0.02
Book Value
0.44

Technical Indicators

52 Week High
GBX 176.25
52 Week Low
GBX 112.25
50 Day MA
GBX 153.68
200 Day MA
GBX 149.37
Beta
0.94

Valuation

Trailing P/E
N/A
Forward P/E
192.31
Price/Sales
4.05
Price/Book
3.74
Enterprise Value
$129.97M